<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01074658</url>
  </required_header>
  <id_info>
    <org_study_id>Advance</org_study_id>
    <nct_id>NCT01074658</nct_id>
  </id_info>
  <brief_title>CoreValve Advance International Post Market Study</brief_title>
  <official_title>CoreValve Advance International Post Market Study: Evaluation of the Medtronic CoreValve System in a &quot;Real-World&quot; Patient Population.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Bakken Research Center</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Cardiovascular</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The CoreValve Advance study is intended to evaluate the clinical utility of the Medtronic
      CoreValve System in a &quot;Real-World&quot; patient population.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The CoreValve Advance study is intended to evaluate the clinical utility of the Medtronic
      CoreValve System for percutaneous aortic valve implantation in a &quot;Real-World&quot; patient
      population with severe aortic valve stenosis. Data collected in this study will provide
      additional information on the understanding of the safety and device performance and how to
      best treat elderly patients with severe aortic valve stenosis. In addition, health economic
      data will be collected to understand the improvement of quality of life and the cost
      effectiveness of the therapy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2010</start_date>
  <completion_date type="Actual">May 2017</completion_date>
  <primary_completion_date type="Actual">November 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Major Adverse Cardiac &amp; Cerebrovascular Events (MACCE)</measure>
    <time_frame>30 days</time_frame>
    <description>MACCE is defined as a composite of:
All cause mortality
Myocardial Infarction (Q-wave and non-Q-wave)
Emergent cardiac surgery or percutaneous re-intervention
Stroke
The Kaplan-Meier survival analysis was used to derive the freedom from MACCE at 30 days.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With Device Success</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>Device Success is defined as a composite of:
Successful device delivery;
Stable device placement;
Intact retrieval of delivery catheter;
Successful device function as assessed immediately post-procedure by angiography including non-compromised flow in coronary arteries (without obstruction) device position (no migration) and a mean gradient as determined invasively of &lt;15mmHg and ≤ 2 aortic regurgitation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With Procedural Success</measure>
    <time_frame>up to 30 days</time_frame>
    <description>Procedural success, defined as device success with absence of in-hospital MACCE</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">1015</enrollment>
  <condition>Severe Aortic Stenosis</condition>
  <arm_group>
    <arm_group_label>severe aortic valve stenosis</arm_group_label>
    <description>elderly patients with severe aortic valve stenosis requiring treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Medtronic CoreValve System</intervention_name>
    <description>Transcatheter Aortic Valve Implantation of the Medtronic CoreValve System</description>
    <arm_group_label>severe aortic valve stenosis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with severe aortic valve stenosis requiring treatment, who are selected to be
        treated electively with the Medtronic CoreValve System
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with severe aortic valve stenosis requiring treatment

          -  Patient is an acceptable candidate for elective treatment with the Medtronic CoreValve
             System and in conformity with the local regulatory and medico economical context

          -  Patient is above the minimum age as required by local regulations to be participating
             in a clinical study

          -  The patient or legal representative has been informed of the nature of the study and
             has consented to participate, and has authorized the collection and release of his/her
             medical information by signing a consent form (&quot;Patient Informed Consent Form&quot;)

        Exclusion Criteria:

          -  Currently participating in another trial

          -  High probability of non-adherence to the follow-up requirements (due to social,
             psychological or medical reasons)

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Axel Linke, Prof Dr med</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitat Leipzig Herzzentrum</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>ZNA Antwerpen Middelheim</name>
      <address>
        <city>Antwerpen</city>
        <zip>2020</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Antwerpen UZA</name>
      <address>
        <city>Antwerp</city>
        <zip>2650</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Sart Tillman</name>
      <address>
        <city>Liege</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Angiografia de Occidente</name>
      <address>
        <city>Cali</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>DK2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Henri Mondor</name>
      <address>
        <city>Creteil</city>
        <zip>94010</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Cardiologique</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Louis Pradel</name>
      <address>
        <city>Lyon</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut Hospitalier Jacques Cartier</name>
      <address>
        <city>Massy</city>
        <zip>91300</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier Pitie-Salpetriere</name>
      <address>
        <city>Paris Cedex</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Pasteur</name>
      <address>
        <city>Toulouse Cedex</city>
        <zip>31076</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Aachen</name>
      <address>
        <city>Aachen</city>
        <zip>52057</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bernau Herzzentrum Brandenburg</name>
      <address>
        <city>Bernau b. Berlin</city>
        <zip>16321</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CardioVascular Center Frankfurt</name>
      <address>
        <city>Frankfurt</city>
        <zip>60389</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asklepios Klinik St. Georg Hamburg</name>
      <address>
        <city>Hamburg</city>
        <zip>20099</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitat Leipzig Herzzentrum</name>
      <address>
        <city>Leipzig</city>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Deutsches Herzzentrum Munchen</name>
      <address>
        <city>Munchen</city>
        <zip>80636</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helios Herzzentrum Siegburg Gmbh</name>
      <address>
        <city>Siegburg</city>
        <zip>53721</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Onassis cardiac surgery center</name>
      <address>
        <city>Athens</city>
        <zip>17674</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hadassah Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <zip>91120</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <zip>52621</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ichilov Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <zip>64239</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliere Spedali Civili di Brescia</name>
      <address>
        <city>Brescia</city>
        <zip>25123</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Policlinico Vittorio Emanuele, P.O. Ferrarotto</name>
      <address>
        <city>Catania</city>
        <zip>95024</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero-Universitaria Careggi</name>
      <address>
        <city>Firenze</city>
        <zip>50134</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Civile</name>
      <address>
        <city>Legnano</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Niguarda Ca'Granda</name>
      <address>
        <city>Milano</city>
        <zip>20025</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fondazione Centro San Raffaele</name>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Istituto Clinico S.Ambrogio</name>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Istituto Clinico Humanitas</name>
      <address>
        <city>Rozzano</city>
        <zip>20089</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AMC Ziekenhuis</name>
      <address>
        <city>Amsterdam</city>
        <zip>1100 DD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Amphia Breda</name>
      <address>
        <city>Breda</city>
        <zip>4818 CK</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Catharina Hospital</name>
      <address>
        <city>Eindhoven</city>
        <zip>5623 EJ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Antonius Ziekenhuis</name>
      <address>
        <city>Nieuwegein</city>
        <zip>3435 CM</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Santa Cruz</name>
      <address>
        <city>Lisbon</city>
        <zip>2799-523</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro Hospitalar de Vila Nova de Gaia</name>
      <address>
        <city>Porto</city>
        <zip>4400</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universtiy Hospital Isel Bern</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsspital Zürich</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brighton and Sussex Hospital</name>
      <address>
        <city>Brighton</city>
        <zip>BN25BE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Leeds General Infirmary</name>
      <address>
        <city>Leeds</city>
        <zip>LS13EX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Leicester Hospital</name>
      <address>
        <city>Leicester</city>
        <zip>Le3 9 QP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. George`s Hospital</name>
      <address>
        <city>London</city>
        <zip>SW170QT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Heart Hospital</name>
      <address>
        <city>London</city>
        <zip>W1G8PH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Newcross Hospital Wolverhampton</name>
      <address>
        <city>Wolverhampton</city>
        <zip>WV10 OEN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Colombia</country>
    <country>Denmark</country>
    <country>France</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Portugal</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
  </location_countries>
  <removed_countries>
    <country>Austria</country>
    <country>Spain</country>
    <country>Sweden</country>
  </removed_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 23, 2010</study_first_submitted>
  <study_first_submitted_qc>February 23, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 24, 2010</study_first_posted>
  <results_first_submitted>July 13, 2016</results_first_submitted>
  <results_first_submitted_qc>August 30, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 21, 2016</results_first_posted>
  <last_update_submitted>October 25, 2017</last_update_submitted>
  <last_update_submitted_qc>October 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Advance</keyword>
  <keyword>Medtronic CoreValve System</keyword>
  <keyword>International</keyword>
  <keyword>Interventional</keyword>
  <keyword>Post Market Study</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Start Recruitment March 2010 &gt; End Recruitment July 2011</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Medtronic CoreValve System</title>
          <description>Transcatheter Aortic Valve Implantation (TAVI) with the Medtronic CoreValve System.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1015"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Attempted Implant</title>
              <participants_list>
                <participants group_id="P1" count="996"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="996"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>No implant attempted</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Medtronic CoreValve System</title>
          <description>Transcatheter Aortic Valve Implantation (TAVI) with the Medtronic CoreValve System.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1015"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="81.1" spread="6.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="514"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="501"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Major Adverse Cardiac &amp; Cerebrovascular Events (MACCE)</title>
        <description>MACCE is defined as a composite of:
All cause mortality
Myocardial Infarction (Q-wave and non-Q-wave)
Emergent cardiac surgery or percutaneous re-intervention
Stroke
The Kaplan-Meier survival analysis was used to derive the freedom from MACCE at 30 days.</description>
        <time_frame>30 days</time_frame>
        <population>All attempted population.</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic CoreValve System</title>
            <description>Transcatheter Aortic Valve Implantation (TAVI) with the Medtronic CoreValve System</description>
          </group>
        </group_list>
        <measure>
          <title>Major Adverse Cardiac &amp; Cerebrovascular Events (MACCE)</title>
          <description>MACCE is defined as a composite of:
All cause mortality
Myocardial Infarction (Q-wave and non-Q-wave)
Emergent cardiac surgery or percutaneous re-intervention
Stroke
The Kaplan-Meier survival analysis was used to derive the freedom from MACCE at 30 days.</description>
          <population>All attempted population.</population>
          <units>Freedom from MACCE (%) @30days</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="996"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With Device Success</title>
        <description>Device Success is defined as a composite of:
Successful device delivery;
Stable device placement;
Intact retrieval of delivery catheter;
Successful device function as assessed immediately post-procedure by angiography including non-compromised flow in coronary arteries (without obstruction) device position (no migration) and a mean gradient as determined invasively of &lt;15mmHg and ≤ 2 aortic regurgitation</description>
        <time_frame>up to 24 hours</time_frame>
        <population>All attempted population in which the separate variables related to device success (see outcome measure description) were analyzable.</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic CoreValve System</title>
            <description>Transcatheter Aortic Valve Implantation (TAVI) with the Medtronic CoreValve System</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Device Success</title>
          <description>Device Success is defined as a composite of:
Successful device delivery;
Stable device placement;
Intact retrieval of delivery catheter;
Successful device function as assessed immediately post-procedure by angiography including non-compromised flow in coronary arteries (without obstruction) device position (no migration) and a mean gradient as determined invasively of &lt;15mmHg and ≤ 2 aortic regurgitation</description>
          <population>All attempted population in which the separate variables related to device success (see outcome measure description) were analyzable.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="578"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With Procedural Success</title>
        <description>Procedural success, defined as device success with absence of in-hospital MACCE</description>
        <time_frame>up to 30 days</time_frame>
        <population>All attempted population in which the separate variables related to procedural success (see outcome measure description) were analyzable.</population>
        <group_list>
          <group group_id="O1">
            <title>Medtronic CoreValve System</title>
            <description>Transcatheter Aortic Valve Implantation (TAVI) with the Medtronic CoreValve System</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Procedural Success</title>
          <description>Procedural success, defined as device success with absence of in-hospital MACCE</description>
          <population>All attempted population in which the separate variables related to procedural success (see outcome measure description) were analyzable.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="613"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>30 days post procedure</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Medtronic CoreValve System</title>
          <description>Transcatheter Aortic Valve Implantation (TAVI) with the Medtronic CoreValve System</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="541" subjects_at_risk="996"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac tamponade</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="996"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="996"/>
              </event>
              <event>
                <sub_title>Ventricular fibrillation</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="996"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" events="18" subjects_affected="18" subjects_at_risk="996"/>
              </event>
              <event>
                <sub_title>Myocardial Infarction</sub_title>
                <description>Myocardial infarction was defined according to the definition proposed by the The Joint ESC/ACC/AHA/WHF Task Force and Academic Research Consortium.(Thygesen K, Alpert JS, White HD. Circulation. 2007;116:2634-2653)</description>
                <counts group_id="E1" events="110" subjects_affected="110" subjects_at_risk="996"/>
              </event>
              <event>
                <sub_title>Structural Valve Deterioration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="996"/>
              </event>
              <event>
                <sub_title>Nonstructural Valve Dysfunction</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="996"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" events="45" subjects_affected="45" subjects_at_risk="996"/>
              </event>
              <event>
                <sub_title>Other Serious Adverse Event</sub_title>
                <counts group_id="E1" events="286" subjects_affected="213" subjects_at_risk="996"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Vessel dissection</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="996"/>
              </event>
              <event>
                <sub_title>Access site complication</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="996"/>
              </event>
              <event>
                <sub_title>Access vessel dissection</sub_title>
                <counts group_id="E1" events="21" subjects_affected="21" subjects_at_risk="996"/>
              </event>
              <event>
                <sub_title>Access vessel perforation</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="996"/>
              </event>
              <event>
                <sub_title>Acute vessel occlusion</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="996"/>
              </event>
              <event>
                <sub_title>Hemorrhage requiring transfusion</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="996"/>
              </event>
              <event>
                <sub_title>Reposition with snare</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="996"/>
              </event>
              <event>
                <sub_title>Valve in valve</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="996"/>
              </event>
              <event>
                <sub_title>Valve retrieval</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="996"/>
              </event>
              <event>
                <sub_title>Valve dislocation into LVOT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="996"/>
              </event>
              <event>
                <sub_title>Valve dislocation into annular aorta</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="996"/>
              </event>
              <event>
                <sub_title>Ventricular rupture</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="996"/>
              </event>
              <event>
                <sub_title>Other Procedural Complication</sub_title>
                <counts group_id="E1" events="25" subjects_affected="23" subjects_at_risk="996"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Stroke/TIA</sub_title>
                <counts group_id="E1" events="30" subjects_affected="30" subjects_at_risk="996"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal Failure</sub_title>
                <counts group_id="E1" events="36" subjects_affected="35" subjects_at_risk="996"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Resuscitation</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="996"/>
              </event>
              <event>
                <sub_title>Failure of closure device requiring surgery</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="996"/>
              </event>
              <event>
                <sub_title>Permanent Pacemaker Implantation</sub_title>
                <counts group_id="E1" events="209" subjects_affected="209" subjects_at_risk="996"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hemodynamic instability requiring Heart/Lung machine</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="996"/>
              </event>
              <event>
                <sub_title>Bleeding Event</sub_title>
                <description>Any episode of major internal or external bleeding that causes death, hospitalization, or permanent injury (i.e. vision loss) or necessitates transfusion.</description>
                <counts group_id="E1" events="91" subjects_affected="87" subjects_at_risk="996"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="541" subjects_at_risk="996"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>AE related to Device</sub_title>
                <counts group_id="E1" events="101" subjects_affected="84" subjects_at_risk="996"/>
              </event>
              <event>
                <sub_title>AE related to Index procedure</sub_title>
                <counts group_id="E1" events="883" subjects_affected="535" subjects_at_risk="996"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>PI will provide results to sponsor for review and approval at least 60 days prior to submittal for publication or presentation. Review will be limited to determination whether Confidential Information is disclosed and not to censor or interfere with presentation or conclusions beyond the extent necessary to protect Confidential Information, to allow the sponsor to protect its rights in patentable or copyrightable material, and to check for technical correctness of sponsor information.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Hanne Gonnissen</name_or_title>
      <organization>Medronic Bakken Research Center</organization>
      <phone>+3143356 ext 6734</phone>
      <email>hanne.gonnissen@medtronic.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

